Using Nicotine to Reverse Age-related Auditory Processing Deficits
Using Nicotine to Reverse Age-related Auditory Processing Deficits: Human Psychophysics and Electrophysiology
University of California, Irvine
48 participants
Feb 1, 2022
INTERVENTIONAL
Conditions
Summary
The present study will evaluate the effects of both aging and nicotine on psychophysical tasks and electrophysiological measures. Nicotine will be administered to study participants in the form of gum that is available as an over-the-counter medication. The hypothesis is that nicotine will reverse the detrimental effects of aging on auditory processing. The proposed experiments will characterize the effects of nicotine and may eventually lead to improved treatments of hearing loss in a variety of patient populations and in healthy aging.
Eligibility
Inclusion Criteria3
- between 18 and 85 years of age
- non-smokers with a score of 0-2 out of 10 maximum on the Fagerström index of smoking dependency
- cognitive performance within two standard deviations of the CERAD mean
Exclusion Criteria6
- less than 18 or greater than 85 years of age
- deafness or excessive hearing loss
- smokers with a score between 3 and 10 on the Fagerström index of smoking dependency
- history of psychiatric illness, neurological disorders, diabetes mellitus, renal failure, or cardiovascular disease
- regular use of prescription medications (excluding oral contraceptives)
- drug dependency
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Nicotine (6 mg) will be administered in the form of polacrilex gum that is available as an over-the-counter medication
The placebo will also be a commercially available gum that resembles the nicotine gum in flavor, size, shape, color, and texture.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04971954